Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

This study has been withdrawn prior to enrollment.
(failed recruitment efforts)
Sponsor:
Collaborator:
Janssen, LP
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00178854
First received: September 12, 2005
Last updated: February 5, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given